These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16883948)

  • 1. [Pseudoexfoliation syndrome--etiopatogenesis and clinical course].
    Ludwisiak-Kocerba L; Hevelke A; Kecik D
    Klin Oczna; 2006; 108(1-3):82-6. PubMed ID: 16883948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudoexfoliation syndrome (PEX)--a systemic disorder].
    Kurowska AK; Kamińska A; Izdebska J; Szaflik JP; Szaflik J
    Klin Oczna; 2009; 111(4-6):160-4. PubMed ID: 19673450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
    Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
    Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome.
    Schlötzer-Schrehardt U; von der Mark K; Sakai LY; Naumann GO
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):970-84. PubMed ID: 9112993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.
    Naumann GO; Schlötzer-Schrehardt U; Küchle M
    Ophthalmology; 1998 Jun; 105(6):951-68. PubMed ID: 9627642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exfoliation syndrome.
    Ritch R; Schlötzer-Schrehardt U
    Surv Ophthalmol; 2001; 45(4):265-315. PubMed ID: 11166342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression in pseudoexfoliation syndrome.
    Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacoemulsification in pseudoexfoliation (PEX) syndrome.
    Susić N; Kalauz-Surać I; Brajković J
    Acta Clin Croat; 2008 Jun; 47(2):87-9. PubMed ID: 18949903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits].
    Schlötzer-Schrehardt U; Küchle M; Hofmann-Rummelt C; Kaiser A; Kirchner T
    Klin Monbl Augenheilkd; 2000 Jun; 216(6):412-9. PubMed ID: 10919121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of the pseudoexfoliation syndrome on cataract development].
    Napora KJ; Obuchowska I; Mariak Z
    Klin Oczna; 2008; 110(1-3):98-101. PubMed ID: 18669095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic pseudoexfoliation syndrome.
    Schlötzer-Schrehardt U; Naumann GO
    Am J Ophthalmol; 2006 May; 141(5):921-937. PubMed ID: 16678509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.
    Sharma S; Chataway T; Klebe S; Griggs K; Martin S; Chegeni N; Dave A; Zhou T; Ronci M; Voelcker NH; Mills RA; Craig JE
    Mol Vis; 2018; 24():801-817. PubMed ID: 30713420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
    Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
    Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.
    Hammer T; Schlötzer-Schrehardt U; Naumann GO
    Arch Ophthalmol; 2001 Jul; 119(7):1023-31. PubMed ID: 11448324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
    Schlötzer-Schrehardt U
    Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unilateral or asymmetric PEX syndrome? An electron microscopy study].
    Hammer T; Schlötzer-Schrehardt U; Jünemann A
    Klin Monbl Augenheilkd; 2000 Aug; 217(2):100-8. PubMed ID: 11022664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
    Schlötzer-Schrehardt U
    Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoexfoliation syndrome and cataract surgery by phacoemulsification.
    Busić M; Kastelan S
    Coll Antropol; 2005; 29 Suppl 1():163-6. PubMed ID: 16193703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoelectron microscopic localization of the HNK-1 carbohydrate epitope in the anterior segment of pseudoexfoliation and normal eyes.
    Kubota T; Schlötzer-Schrehardt U; Inomata H; Naumann GO
    Curr Eye Res; 1997 Mar; 16(3):231-8. PubMed ID: 9088739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.